Zobrazeno 1 - 10
of 26
pro vyhledávání: '"L J Hirsch"'
Publikováno v:
Neurology. 75(22)
Publikováno v:
Intensive Care Medicine ISBN: 9781475755534
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a305561be5598499cb12750050f52805
https://doi.org/10.1007/978-1-4757-5551-0_68
https://doi.org/10.1007/978-1-4757-5551-0_68
Publikováno v:
BMJ (Clinical research ed.). 323(7326)
Autor:
J. Torgovnick, N. Sethi, E. Arsura, J. B. Martin, S. R. Benbadis, R. E. Faught, J. Sirven, J. D. Slater, M. R. Sperling, L. J. Hirsch
Publikováno v:
Neurology. 75:2045-2046
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 8
Autor:
D B, Karpf, D R, Shapiro, E, Seeman, K E, Ensrud, C C, Johnston, S, Adami, S T, Harris, A C, Santora, L J, Hirsch, L, Oppenheimer, D, Thompson
Publikováno v:
JAMA. 277(14)
To evaluate the effect of treatment with alendronate sodium, a potent aminobisphosphonate, on the incidence of nonvertebral fractures in postmenopausal women with osteoporosis.Published data and data on file at Merck Research Laboratories.All complet
Autor:
G A, Rodan, L J, Hirsch
Publikováno v:
Hormone research. 45(6)
Autor:
L J, Hirsch, S, Pryor-Tillotson
Publikováno v:
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.
The purpose of this overview is to provide a summary of recent data on the clinical safety and efficacy of alendronate sodium, an amino-bisphosphonate that is a potent and specific inhibitor of osteoclast mediated bone resorption, in the treatment of
Autor:
Howard N. Hodis, D M Kramsch, L I Vailas, L J Hirsch, Stanley P. Azen, Linda Cashin-Hemphill, M J Masteller, Petar Alaupovic, David H. Blankenhorn, Wendy J. Mack, L W DeBoer, Peter R. Mahrer
Publikováno v:
Annals of internal medicine. 119(10)
To assess the effects of lipid-lowering therapy with lovastatin on coronary angiographic findings in patients with coronary artery disease and to compare the findings with those of two lipid-lowering angiographic trials using similar end points.Rando
Autor:
L, Cashin-Hemphill, D M, Kramsch, S P, Azen, D, DeMets, L W, DeBoer, I, Hwang, L, Vailas, L J, Hirsch, W J, Mack, L, DeBoer
Publikováno v:
The Online journal of current clinical trials.
The Monitored Atherosclerosis Regression Study (MARS) was designed to evaluate the effect of cholesterol lowering by monotherapy with an HMG-CoA reductase inhibitor on progression/regression of atherosclerosis in subjects with angiographically docume